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Abstract The histological differential diagnosis between
melanotic schwannoma, primary leptomeningeal melano-
cytic lesions and cellular blue nevus can be challenging.
Correct diagnosis of melanotic schwannoma is important to
select patients who need clinical evaluation for possible
association with Carney complex. Recently, we described
the presence of activating codon 209 mutations in the
GNAQ gene in primary leptomeningeal melanocytic
lesions. Identical codon 209 mutations have been described
in blue nevi. The aims of the present study were to (1)
perform a histological review of a series of lesions (ini-
tially) diagnosed as melanotic schwannoma and analyze
them for GNAQ mutations, and (2) test the diagnostic value
of GNAQ mutational analysis in the differential diagnosis
with leptomeningeal melanocytic lesions. We retrieved 25
cases that were initially diagnosed as melanotic schwan-
noma. All cases were reviewed using established criteria
and analyzed for GNAQ codon 209 mutations. After review,
nine cases were classiﬁed as melanotic schwannoma.
GNAQ mutations were absent in these nine cases. The
remaining cases were reclassiﬁed as conventional schwan-
noma (n = 9), melanocytoma (n = 4), blue nevus (n = 1)
and lesions that could not be classiﬁed with certainty as
melanotic schwannoma or melanocytoma (n = 2). GNAQ
codon 209 mutations were present in 3/4 melanocytomas
and the blue nevus. Including results from our previous
study in leptomeningeal melanocytic lesions, GNAQ
mutations were highly speciﬁc (100%) for leptomeningeal
melanocytic lesions compared to melanotic schwannoma
(sensitivity 43%). We conclude that a detailed analysis of
morphology combined with GNAQ mutational analysis can
aid in the differential diagnosis of melanotic schwannoma
with leptomeningeal melanocytic lesions.
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Introduction
Melanotic schwannoma is a rare variant of schwannoma
composed of cells having the ultrastructure and
immunophenotype of Schwann cells but containing mel-
anosomes in varying stages of maturation [24, 25]. They
show a peak incidence in the fourth decade, and affect
males and females equally. About half of these tumors
arise in close proximity to the neural axis. These neo-
plasms are often associated with spinal nerve roots,
cranial nerves or arising from the paraspinal sympathetic
chain [5, 15]. The other half arises in a wide variety of
sites including the gastrointestinal tract, soft tissues, skin,
heart and liver [3, 8, 10, 13, 25]. The biological behavior
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metastasis reported in up to 10% of cases, sometimes
even in the absence of histological features suggestive of
aggressive behavior [5, 27]. A speciﬁc subgroup of mel-
anotic schwannomas contains psammoma calciﬁcations.
About half of these so-called psammomatous melanotic
schwannomas occur in the setting of the autosomal
dominant Carney complex, a multiple neoplasia syndrome
characterized by a markedly increased risk to develop
myxomas, mucocutaneous lentigines and blue nevi,
endocrine hyperactivity and/or psammomatous melanotic
schwannomas [5]. Isolated cases of non-psammomatous
melanotic schwannomas have been associated with Car-
ney complex as well [6]. Nearly two-thirds of patients
with Carney complex have mutations spread over the
PRKAR1A gene, which encodes the R1a regulatory sub-
unit of cyclic-AMP-dependent protein kinase A [14, 29].
The differential diagnosis between melanotic schwan-
nomas and pigmented melanocytic lesions can be difﬁcult,
especially in small biopsy specimens. It includes primary
or metastatic melanoma, a diagnosis with obvious prog-
nostic and therapeutic relevance. In addition, melanotic
schwannomas may histologically closely resemble lepto-
meningeal melanocytomas and cellular blue nevi [20].
Immunohistochemical stains are not always useful in
sorting out this differential diagnosis. All these lesions
generally express S-100 (which can be explained by their
common neural crest origin) and one or more melanocytic
markers. Although stains for components of the basement
membrane can be useful in discriminating tumors with
schwannian differentiation from tumors with melanocytic
differentiation, overlap in staining patterns has been noted
and can impair interpretation, especially in small biopsy
specimens [4, 12, 21, 26].
Recently, we reported the presence of activating muta-
tions in the GNAQ gene at codon 209 in primary
leptomeningeal melanocytomas (50%) and melanomas
(25%) [16]. The GNAQ gene maps on chromosome 9q21,
and encodes the a-subunit of a heterotrimeric GTP-binding
protein that couples G-protein-coupled receptor signaling
to the MAP kinase pathway [22]. GNAQ codon 209
mutations form an alternative route to MAP kinase acti-
vation [28]. Identical oncogenic mutations in the GNAQ
gene have been reported in blue nevi (83%) and uveal
melanoma (46%) [17, 28].
The aims of the present study were (1) to perform a
thorough histological review of a series of lesions that were
(initially) diagnosed as melanotic schwannoma and to
analyze these cases for mutations in the GNAQ gene, and
(2) to assess the diagnostic value of GNAQ mutational
analysis in the differential diagnosis of melanotic
schwannoma with primary leptomeningeal melanocytic
lesions by including data from our previous study on
GNAQ mutations in leptomeningeal melanocytic lesions
[16].
Materials and methods
Patients and histopathology
For this retrospective study, formalin ﬁxed and parafﬁn
embedded (FFPE) tissues of melanotic schwannomas were
retrieved from archives of various Departments of Pathol-
ogy in The Netherlands. The cases were obtained through
the Dutch nationwide histopathology and cytopathology
data network and archive (PALGA) [7]. All cases (n = 25)
were initially diagnosed as melanotic schwannomas.
Formalin ﬁxed and parafﬁn embedded tissues were
sectioned at 4 lm, deparafﬁnized, and subjected to antigen
retrieval by limited protein digestion or citrate (CC1) and
microwave treatment. Slides were then incubated at room
temperature with antibodies to S-100 protein (polyclonal,
1:800, Dako Co., Lot 00060051), Melan-A (Mart-1, 1:800,
Neomarkers, Lot 799P807C), HMB-45 (1:50, Neomarkers,
Lot 23068), MIB-1 (Ki-67, 1:200, Dako Co., Lot
00045312), EMA (E-29, 1:50, Dako Co., Lot 00051982),
Collagen type IV (monoclonal, 1:1,250, Sigma, Lot
062K4819) and Laminin (polyclonal, 1:100, Thermo, Lot
82H907B). Amino-ethylcarbazole served as chromogen.
Reticulin stains (Laguesse) were performed on each case.
Schmorl and Perl’s (iron) stains were performed to conﬁrm
melanin pigmentation.
Histology was revised independently by two patholo-
gists (HK, BK) without knowledge of molecular results.
Revision of the slides included scoring of histological
criteria and immunohistochemical stains.
The deposition of basement membrane material in the
reticulin, Collagen type IV and Laminin stains was cate-
gorized into three staining patterns. The pericellular pattern
was represented by an extensive network of basement
membrane material around individual tumor cells, consis-
tent with schwannian differentiation [12, 24]. The nested/
perilobular pattern consisted of deposition of basement
membrane material around nests of tumor cells (rather than
around individual tumor cells), and is typically seen in
melanocytic lesions [26]. The biphasic staining pattern was
characterized by areas with nested staining as well as areas
with pericellular staining, and has been described in mel-
anotic schwannomas [12, 24].
After revision, the cases were reclassiﬁed as (1) mela-
notic schwannoma, with or without psammoma bodies and/
or fat, (2) conventional schwannoma, (3) melanocytoma,
(4) lesion not further classiﬁed with certainty as melanotic
schwannoma or melanocytoma, or (5) blue nevus. Criteria
used for classiﬁcation are presented in Table 1.
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123The diagnosis of ‘melanotic schwannoma’ and ‘con-
ventional schwannoma’ was based on WHO criteria [24].
Additional detailed histological criteria of melanotic
schwannoma were retrieved from Mooi [20], and included
circumscribed, often encapsulated tumors consisting of
spindle to epithelioid cells, with or without psammoma
bodies and/or fat, variable melanin pigmentation, S-100
positivity and expression of Melan-A and/or HMB-45.
Schwannomas lacking positivity for both HMB-45 and
Melan-A were classiﬁed as conventional schwannomas. A
pericellular staining pattern in the basement membrane
stains served as an additional criterion for conventional
schwannoma, while in melanotic schwannomas also a
biphasic staining pattern can be present [12, 24].
The diagnosis of ‘melanocytoma’ was based on histo-
logical criteria as described by Brat et al. [1, 2]. This
included circumscribed, non-encapsulated lesions consist-
ing of nests or fascicles of spindle and/or epithelioid cells
with little nuclear atypia and variable melanin pigmenta-
tion. Immunohistochemical criteria included S-100
positivity, expression of Melan-A and/or HMB-45, and a
nested staining pattern in the basement membrane stains.
Lesions with increased mitotic activity or invasion of
neuroglial tissue were classiﬁed as ‘intermediate-grade’
melanocytomas.
The diagnosis of ‘cellular blue nevus’ was based on
histological criteria described by Mooi [19]. This included
a primary location of the lesion within the dermis with a
biphasic architecture, especially at the base of the lesion,
consisting of nodules and sheets of pale, oval melanocytes
intermingled with pigmented dendritic melanocytes dif-
fusely arranged in sclerotic stroma. For statistical
evaluation, 19 leptomeningeal melanocytic lesions from
our previous study were included [16].
DNA extraction
About ﬁve manually dissected sections of 10 lm FFPE
tissue with an estimated tumor cell percentage of at least
60% were used for DNA extraction. After heating in ATL
buffer, the tissue sections were incubated in proteinase K
for 1 hour, followed by subsequent puriﬁcation of the DNA
according to the manufacturer (QIAamp DNA Mini Kit,
QIAGEN GmbH, Germany). DNA sample concentration
was assessed spectrophotometrically (Varian Cary 50
spectrophotometer, Agilent Technologies).
Mutational analysis
Direct sequence analysis of GNAQ exon 5 was performed
on DNA specimens from 25 pigmented lesions of sch-
wannian or melanocytic origin. PCR ampliﬁcation was
performed in a total volume of 25 ll, containing 50 ng
DNA, PCR-buffer IV (Integro), 37 mM MgCl2, 250 lMo f
dNTPs, 37.5 lg bovine serum albumin (Sigma), 10 pmol
of forward primer (p740, sequence: 50 TGTAAAACGAC
GGCCAGTTTCCCTAAGTTTGTAAGTAGTGC 30) and
reverse primer (p705, sequence: 50 CAGGAAACAGC
TATGACCCTTACCTCATTGTCTGAC 30, or p695,
sequence: 50 TCCATTTTCTTCTCTCTGACC 30) and
0.05 units of thermostable DNA polymerase (Sigma).
Primers p740 and p705 contained a M13 forward and a
M13 reverse consensus sequence, respectively, enabling
standardized sequencing of different exons.
DNA ampliﬁcation was performed in duplicate in a PTC
200 Thermal Cycler (MJ Research). The PCR was started
with 5 min at 92C and followed with 35 cycles of dena-
turation 45 s at 94C, annealing at 62C for 45 s and
extension at 72C for 45 s, followed by a ﬁnal extension at
72C for 20 min and cooling down for 5 min at 20C. PCR
products were puriﬁed with MinElute plates (Qiagen).
After analyzing the PCR products by agarose gel electro-
phoresis (2%; Invitrogen), 1–4 ll of the PCR products was
sent in for sequence analysis using an ABI PRISM 3700
DNA analyzer (Applied Biosystems).
Because the DNA quality of some specimens was sub-
optimal, different primer combinations were used in the
PCR. The DNA samples of cases 1, 2, 3, 5, 6, 13, 14, 22
and 23 were of sufﬁcient quality and the primer combi-
nation p740 and p705, yielding a PCR product of 224 base
pairs (bp), was used for DNA ampliﬁcation. Sequence
analysis was performed using the M13 forward primer and
reverse primer on duplicate DNA ampliﬁcations of the
same specimen. For the DNA samples that were strongly
degraded (cases 4, 7, 8, 9, 10, 11, 12, 15, 16, 17, 18, 19, 20,
21, 24, 25), the primer combination p740 and p695,
yielding a PCR product of 134 bp, was used. Sequence
analysis (in duplicate) of these samples was performed
using the forward primer only, since the reverse primer
p695 is closely ﬂanking the mutation hotspot. By sequence
analysis of the entire PCR products, it was shown that the
primers used speciﬁcally ampliﬁed the GNAQ gene
(accession nr: NM_002072.2) and not its pseudogene
(GNAQP1; accession nr: NG_000862.4v). The ampliﬁed
gene sequence was speciﬁc for the GNAQ gene, and
nucleotides that are present in the pseudogene were not
detected [9].
Statistical analysis
The diagnostic value of GNAQ mutational analysis in the
differential diagnosis of melanotic schwannoma with pri-
mary leptomeningeal melanocytic lesions was tested using
additional data from our previous study on GNAQ muta-
tions in primary leptomeningeal melanocytic lesions [16].
Sensitivity and speciﬁcity of GNAQ mutational analysis
758 Acta Neuropathol (2010) 120:755–764
123were calculated. To assess whether the difference in GNAQ
mutational status between melanotic schwannoma and
leptomeningeal melanocytic lesions was statistically sig-
niﬁcant, we performed Fisher’s exact test (SPSS 16.0 for
Windows).
Results
Patient and histopathological characteristics
We retrieved 25 lesions initially diagnosed as melanotic
schwannomas from the archives of various Departments of
Pathology in The Netherlands. After revision, the lesions
were reclassiﬁed using the above-mentioned criteria into
nine melanotic schwannomas, nine conventional schwan-
nomas, four melanocytomas, one blue nevus and ﬁnally
two lesions that could not be further classiﬁed with cer-
tainty as melanotic schwannoma or melanocytoma. Patient
and histopathological characteristics are summarized in
Table 2. As far as data were available, the melanotic sch-
wannomas had an equal sex distribution and the mean age
was 37.2 years. Most melanotic schwannomas were loca-
ted around the spinal cord (7/9), while two lesions were
located in the extremities (lower arm and lower leg). As far
as could be evaluated on the slides, melanotic schwanno-
mas were circumscribed, encapsulated tumors (6/9)
(Fig. 1a) with variably but mostly intense melanin pig-
mentation (6/9) (Fig. 1b). Eight of nine melanotic
schwannomas contained psammoma bodies (Fig. 1a, b)
and, in addition, one melanotic schwannoma contained
large, empty vacuoles resembling fat (Fig. 1c). Tumor cells
were arranged in sheets and fascicles and varied from
spindle to epithelioid, often with nuclear pseudoinclusions
(Fig. 1c) and conspicuous nucleoli. In some cases, there
was nuclear palisading and one case showed Antoni A and
B areas together with Verocay bodies (case 4). Marked
nuclear pleomorphism, necrosis, and invasion in sur-
rounding structures were absent. These tumors were all
negative in the EMA stains (excluding meningioma). MIB-
1 staining was less than 1%. S-100 stains showed a diffuse
and strong expression in all melanotic schwannomas
(Fig. 1d). In addition, all lesions showed positivity for
Melan-A and HMB-45 (Fig. 1e). Reticulin, Collagen type
IV and Laminin stains showed in four of nine cases an
extensive network of basement membrane material around
individual tumor cells (pericellular pattern), consistent with
schwannian differentiation (Fig. 1f). In ﬁve melanotic
schwannomas, a biphasic staining pattern was present
consisting of areas with pericellular deposition of basement
membrane material next to areas with deposition around
nests of tumor cells (nested/perilobular pattern). One lesion
initially diagnosed elsewhere as a ‘peripherally located
melanotic schwannoma’ was reclassiﬁed as a cellular blue
nevus (case 19) [19].
Nine lesions initially diagnosed elsewhere as melanotic
schwannoma were reclassiﬁed as conventional schwan-
nomas. These lesions showed the typical histological
features of schwannomas with frequent Antoni A and B
areas, nuclear palisading, blood vessel hyalinization and
wavy nuclei. We did not classify them as melanotic
schwannoma, because positivity for both Melan-A and
HMB-45 was lacking. They all contained focally some
ﬁne intracytoplasmic grayish pigment in tumor cells
(Schmorl positive). Furthermore, extensive areas with
deposition of basement membrane material around indi-
vidual tumor cells in the basement membrane stains were
present. Based on the criteria described by Brat et al. [1,
2], four lesions located around the spinal cord were
reclassiﬁed as melanocytomas. Three of them showed an
inﬁltrative growth pattern in the neuroglial tissues and
were classiﬁed as intermediate-grade melanocytomas
(Fig. 2a). All lesions consisted of fascicles and nests of
spindle and/or epithelioid cells with variable melanin
pigment. Nuclei were round to oval and uniform in size,
with mostly small nucleoli (Fig. 2b). Prominent nuclear
atypia was absent. In contrast to the melanotic and con-
ventional schwannomas, S-100 was only focally positive
(Fig. 2c), while Melan-A and HMB-45 were more dif-
fusely positive (Fig. 2d, e). MIB-1 staining was less than
1% in all cases. Reticulin, Collagen type IV and Laminin
stains showed deposition of basement membrane material
around vascular structures and nests of tumor cells (nes-
ted/perilobular), but not around individual tumor cells
(Fig. 2f).
Finally, two lesions could not be classiﬁed with cer-
tainty into melanotic schwannoma or melanocytoma (cases
24 and 25). Case 24 was a variably, partly heavily pig-
mented lesion consisting of spindle to pleiomorphic cells
(Fig. 3a, c). The lesion showed inﬁltrative growth in or
from a ganglion at the lumbar spinal region (Fig. 3b). The
nuclei showed moderate to strong atypia with conspicuous
nucleoli (Fig. 3c). MIB-1 staining was less than 10%.
Psammoma bodies were absent. S-100, Melan-A and
HMB-45 stains were diffusely positive. The reticulin,
Collagen type IV and Laminin stains showed a biphasic
pattern (Fig. 3d, e). Based on these histological features,
we favored the diagnosis of melanotic schwannoma with
atypical features suggestive of aggressive behavior. For
case 25, only limited biopsy material was available which
impaired unequivocal histological assessment. It concerned
a heavily pigmented lesion located at the cerebellopontine
angle consisting of spindle cells with mild cytonuclear
atypia and small nucleoli. S-100 was focally positive, while
the Melan-A and HMB-45 stains were diffusely positive. A
nested/perilobulated staining pattern was present in the
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123reticulin, Collagen type IV and Laminin stains. In this case,
we favored the diagnosis of melanocytoma.
Results of GNAQ mutational analysis
All lesions were tested for mutations in exon 5 of the GNAQ
gene. The results are presented in Table 2. We detected
mutations in exon 5 of GNAQ in three of four melanocy-
tomas and the blue nevus (c626A[T, pGln209Leu). No
mutations were detected in melanotic or conventional sch-
wannomas. In the two lesions which we could not classify
with certainty as melanotic schwannoma or melanocytoma
(cases 24 and 25), only case 25 (the probable melanocytoma
case) had a mutation in codon 209 of exon 5 (c626A[T,
pGln209Leu).
Diagnostic value of GNAQ mutational analysis
In our previous study on GNAQ mutations in primary
leptomeningeal melanocytic lesions [16], codon 209
mutations of GNAQ were present in 7 of 19 lesions. Taking
these previous results into account, a total GNAQ mutation
frequency of 43% (10/23) in primary leptomeningeal
melanocytic lesions was detected. No GNAQ mutations
were detected in the melanotic schwannomas. The muta-
tional status between melanotic schwannoma and
leptomeningeal melanocytic lesions was signiﬁcantly dif-
ferent (P = 0.030). GNAQ mutations were highly speciﬁc
for leptomeningeal melanocytic lesions compared to mel-
anotic schwannoma (100%); however, sensitivity for
leptomeningeal melanocytic lesions was low (43%).
Discussion
Especially on biopsy material, the differential diagnosis of
melanotic schwannoma with primary leptomeningeal mel-
anocytic lesions and, in case of peripherally located lesions,
cellular blue nevi can pose a problem to pathologists, since
these lesions have overlapping histological features and
immunohistochemical stains are not always useful. All
these lesions are variably pigmented, spindle and/or epi-
thelioid cell tumors, expressing S-100 (owing to their
common neural crest origin) and one or more melanocytic
Fig. 1 Melanotic schwannoma
(case 4) showing a
circumscribed tumor, covered
by a ﬁbrous capsule and
containing several psammoma
bodies (a)( 950). Detail of the
same lesion showing spindle
cell morphology, an ample
amount of melanin pigment and
a psammoma body (case 4)
(b)( 9200). Melanotic
schwannoma (case 8) with more
epithelioid cell morphology,
nuclear pseudoinclusions
(arrow) and large vacuoles
resembling fat (c)( 9400).
Strong and diffuse positivity for,
respectively, S-100 and HMB-
45 in a melanotic schwannoma
(case 4) (d, e)( 925, 9100).
Same lesion with pericellular
deposition of basement
membrane material (case 4)
(f) (Laguesse stain, 9400)
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123Fig. 2 Intermediate-grade
melanocytoma (case 20) with
invasion of neuroglial tissue;
note the Rosenthal ﬁbers
(arrow) in the surrounding
neuropil (a)( 9200). Epithelioid
cell morphology with bland
nuclei and small nucleoli in a
melanocytoma (case 22)
(b)( 9400). Focal positivity for
S-100 in the same lesion (case
22) (c)( 9200). Diffuse
positivity for HMB-45 and
Melan-A, respectively, in the
same lesion (d, e) and a nested
staining pattern in the reticulin
stain (f) (case 22) (Laguesse
stain, 9200)
Fig. 3 Case 24 was a variably,
partly heavily pigmented lesion
consisting of spindle to
pleomorphic cells (a, c)( 9200),
showing inﬁltrative growth in a
ganglion at the lumbar spinal
region with dispersed
incorporated ganglion cells
(arrow)( b)( 9400). The nuclei
showed marked atypia with
conspicuous nucleoli
(c)( 9200). In the reticulin stain,
both a pericellular (d) and
nested staining pattern were
seen (e) (Laguesse, 9100). We,
therefore, favored the diagnosis
of a melanotic schwannoma
with atypical features
suggestive of aggressive
behavior. Molecular analysis of
this case did not reveal
mutations in the GNAQ gene
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123markers. However, some histological features favor the
diagnosis of melanotic schwannoma, such as circum-
scribed, often encapsulated growth, and/or the presence of
psammoma bodies. Psammoma bodies are generally absent
in melanocytic tumors, although one case of a psammo-
matous melanoma arising in an intradermal nevus has been
described [18]. Stains for components of the basement
membrane can be useful in discriminating tumors with
schwannian differentiation from tumors with melanocytic
differentiation [12]. Deposition of basement membrane
material around individual tumor cells (‘pericellular’ pat-
tern) is a feature of tumors with schwannian differentiation,
and is generally not pronounced in melanocytic tumors [23,
26]. However, stains for basement membrane in melanin
producing tumors should be interpreted with caution. First,
in melanotic schwannomas, a biphasic staining pattern has
been described with deposition of basement membrane
material around both individual tumor cells as well as
around nests of tumor cells [12], as was the case in ﬁve of
nine melanotic schwannomas in our study. On biopsy
material, with only limited tissue to evaluate, this might
result in misinterpreting the lesion as a melanocytic tumor.
Secondly, most melanomas show the absence of basement
membrane material around individual tumor cells [26],
except for spindle cell melanomas and desmoplastic neu-
rotropic melanomas in which also a biphasic staining
pattern has been described [4, 21, 26].
Recently, we reported the presence of activating muta-
tions in codon 209 of the GNAQ gene in primary
leptomeningeal melanocytic lesions [16]. This gene
encodes the a-subunit of q class heterotrimeric GTP-bind-
ing proteins which couple G-protein-coupled receptors to
the MAP kinase pathway. Identical codon 209 mutations
have been reported in uveal melanoma (46%) and blue nevi
(83%) [28]. These codon 209 mutations occur in the ras-
like domain turning GNAQ into a dominant acting oncogene
[28]. The aim of the present study was to perform a thor-
ough histological review of a series of lesions that were
initially diagnosed as melanotic schwannoma and analyze
these cases for mutations in the GNAQ gene. In addition, we
evaluated the diagnostic value of GNAQ mutational analy-
sis in the sometimes difﬁcult differential diagnosis with
primary leptomeningeal melanocytic lesions. Twenty-ﬁve
cases initially diagnosed as melanotic schwannoma were
reviewed and reclassiﬁed using established criteria into nine
melanotic schwannomas, nine conventional schwannomas,
four melanocytomas, one blue nevus and two lesions that
could not be further classiﬁed with certainty as melanotic
schwannoma or melanocytoma. The fact that in only 9 of 25
cases the initial diagnosis melanotic schwannoma remained
unchanged after review illustrates the difﬁcult differential
diagnosis with esp. conventional schwannoma and lepto-
meningeal melanocytic lesions. Including results from our
previous study [16], a total GNAQ mutation frequency of
43% was present in leptomeningeal melanocytic lesions
(10/23). No GNAQ mutations were detected in the mela-
notic schwannomas (0/9). These results show that GNAQ
mutations are highly speciﬁc for leptomeningeal melano-
cytic lesions compared to melanotic schwannoma (100%).
Thus, GNAQ mutational analysis can have diagnostic value:
in case a GNAQ mutation is present, this supports the
diagnosis of a melanocytic lesion. Here, it is important to
note that lack of a GNAQ mutation does not rule out the
diagnosis of a melanocytic lesion. Correct diagnosis of
melanotic schwannoma has clinical relevance as melanotic
schwannoma can occur in the setting of the autosomal
dominant Carney complex and may require additional
clinical investigations. GNAQ codon 209 mutations in blue
nevi have been reported in up to 83% [28]. This high
mutation frequency suggests that GNAQ mutational analy-
sis can also be useful in the differential diagnosis of
peripherally located melanotic schwannoma with blue
nevus. Noteworthy, we reclassiﬁed a substantial number of
lesions initially diagnosed as melanotic schwannoma into
conventional schwannoma (n = 9), based on the absence of
staining for Melan-A and HMB-45. These lesions all con-
tained some areas with ﬁne intracytoplasmic grayish
Schmorl positive pigment in tumor cells. However, the
absence of staining for Melan-A and HMB-45 contradicts
the presence of true melanosomes in these cells and sug-
gests that the pigment is rather autophagosome-related (e.g.
neuromelanin, lipofuscin) [11]. Care should thus be taken
not to over-diagnose melanotic schwannoma in order to
prevent unnecessary clinical work-up for Carney complex.
At the moment, it is unclear why mutations in the GNAQ
gene are especially found in a subgroup of melanocytic
lesions, including leptomeningeal melanocytic lesions,
uveal melanomas and blue nevi but not in cutaneous mel-
anoma [16, 17, 28]. The fact that these GNAQ-mutated
melanocytic lesions seem to be derived from non-epithe-
lium related melanocytes may indicate that GNAQ
mutations preferentially occur in melanocytes present in
extra-epithelial structures such as leptomeninges, dermis
and uvea. However, whether the site-speciﬁc occurrence of
GNAQ mutations is a consequence of the mutations them-
selves or represents different target cell populations needs
to be further determined. GNAQ codon 209 mutations seem
to be an early event in the pathogenesis since they occur in
benign as well as malignant melanocytic lesions. These
activating codon 209 mutations form an alternative route for
MAP kinase activation and probably represent an initial
stimulus for melanocytes to proliferate. Inhibition of
GNAQ-dependent MAP kinase signaling may form a novel
option for targeted therapy of these tumors. In conclusion,
this study illustrates the difﬁcult differential diagnosis of
melanotic schwannoma with leptomeningeal
Acta Neuropathol (2010) 120:755–764 763
123melanocytoma, and shows that a detailed analysis of mor-
phology combined with molecular analysis of the GNAQ
hotspot mutation can aid herein. Correct diagnosis of mel-
anotic schwannoma is important to select those patients
who need further clinical evaluation for possible association
with Carney complex.
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